![Hendrik Nogai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hendrik Nogai
Chief Tech/Sci/R&D Officer at RYVU THERAPEUTICS S.A.
Profile
Dr. Hendrik Nogai, MD, is a Chief Medical Officer at Ryvu Therapeutics SA. Dr. Nogai was previously employed as a Vice President by Bayer Pharmaceuticals /Switzerland/.
He received his doctorate degree from Ludwig-Maximilians-Universität München, a doctorate degree from Charité - Universitätsmedizin Berlin and a doctorate degree from Harvard Medical School.
Hendrik Nogai active positions
Companies | Position | Start |
---|---|---|
RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 31/01/2022 |
Former positions of Hendrik Nogai
Companies | Position | End |
---|---|---|
Bayer Pharmaceuticals /Switzerland/ | Corporate Officer/Principal | 31/12/2021 |
Training of Hendrik Nogai
Charité - Universitätsmedizin Berlin | Doctorate Degree |
Ludwig-Maximilians-Universität München | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RYVU THERAPEUTICS S.A. | Health Technology |
Private companies | 1 |
---|---|
Bayer Pharmaceuticals /Switzerland/ |
- Stock Market
- Insiders
- Hendrik Nogai